Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-12-30
1998-04-07
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 49, C07H 1906, C07H 19067, C07H 19073, C07H 1909
Patent
active
057365318
ABSTRACT:
The subject invention discloses compounds, compositions and methods for treatment and prevention of toxicity due to chemotherapeutic agents and antiviral agents. Disclosed are acylated derivatives of non-methylated pyrimidine nucleosides. These compounds are capable of attenuating damage to the hematopoietic system in animals receiving antiviral or antineoplastic chemotherapy.
REFERENCES:
patent: 4757139 (1988-07-01), Kawaguchi et al.
patent: 4874602 (1989-10-01), Calabresi et al.
patent: 4950466 (1990-08-01), Calabresi et al.
patent: 5077280 (1991-12-01), Sommadossi et al.
Martin et al. Cancer Chemo. Pharm. 24:9-14, 1989.
D.S. Martin et al., "High-Dose 5-Fluorouracil With Delayed Uridine `Rescue` in Mice", Cancer Res., 42, 3964-3970, 1982.
D.S. Martin et al., "Improved Therapeutic Index with Sequential N-Phosphonacetyl-L-aspartate plus High-Dose Methotrexate plus High-Dose 5-Fluorouracil and Appropriate Rescue," Cancer Res., 43, 4653, 1983.
Proceedings of AACR, 28, 195, Mar. 1987--No. 775--"Phase I Clinical And Pharmacokinetics Study Of Orally Administered Uridine".
C.J. van Groeningen et al., "Clinical and Pharmacokinetic Studies of Prolonged Administration of High-Dose Uridine Intended for Rescue From 5-FU Toxicity," Cancer Treatment Reports, vol. 70, No. 6, 745, Jun. 1986.
N.I. Belyanchikova et al., "Particular Features Of Hematopoiesis In Mice Protected By Deoxycytidine Against The Lethal Effect Of Cytosar," Byulleten` Eksperimental`noi Biologii i Meditsiny, vol. 91, No. 1, pp. 67-69, 1981.
K. Bhalla et al., "Deoxycytidine Preferentially Protects Normal Versus Leukemic Myeloid Progenitor Cells From Cytosine Arabinoside-Mediated Cytotoxicity," Blood, vol. 70, No. 2, Aug. 1987, pp. 568-571.
S. Grant et al., "Interaction Of Deoxycytidine And Deoxycytidine Analogs In Normal And Leukemic Human Myeloid Progenitor Cells," Leukemia Research, M.S. 045, Pergamon Journals Ltd., 1986.
K. Bhalla et al., "Phase I Clinical and Pharmacologic Study of Deoxycytidine," Leukemia, vol. 2 (10) 709-10, 1988.
J. Sommadossi et al, "Uridine Reverses the Toxicity of 3'-Azido-3'-Deoxythymidine in Normal Human Granulocyte-Macrophage Progenitor Cells In Vitro without Impairment of Antiretroviral Activity," Timicrobial Agents And Chemotherapy, vol. 32, No. 7, pp. 997-1001, Jul. 1988.
A. Falcone et al., "Differential Effect of Benzylacyclouridine on the Toxic and Therapeutic Effects of Azidothymidine in Mice," Blood, vol. 76, No. 11, pp. 2216-2221, (Dec. 1) 1990.
K. Bhalla et al., "2'-Deoxycytidine Protects Normal Human Bone Marrow Progenitor Cells In Vitro Against the Cytotoxicity of 3'-Azido-3'-Deoxy-thymidine With Preservation of Antiretroviral Activity," Blood, vol. 74, No. 6, pp. 1923-1928 (Nov. 1) 1989.
Z.M. Gomez et al., "Antimalarial Activity of a Combination of 5-Fluoroorotate and Uridine in Mice," Antimicrobial Agents And Chemotherapy, vol. 34, No. 7, pp. 1371-1375, Jul. 1990.
Oligonucleotide Products, Sigma Catalog pp. 1736-1738, 1981.
M. Iigo et al, "Differential Effects Of 2,2'-Anhydro-5-Ethyluridine, A Uridine Phosphorylase Inhibitor, On he Antitumor Activity of 5-Fluorouridine And 5-Fluoro-2'-Deoxyuridine," Biochemical Pharmacology, vol. 39, No. 7, 1247 (1990).
P. Calabersi et al., "Benzylacyclouridine Reverses Azidothymidine-Induce Marrow Suppression Without Impairment of Anti-Human Immunodeficiency Virus Activity," Blood, vol. 76, No. 11, pp. 2210-2215 (Dec.) 1990.
W.D. Ensminger et al., "Thymidine 5'-O-Pivaloate, A Prodrug Derivative of Thymidine With Potential Applications In High-Dose Methotrexate Therapy," Biochemical Pharmacology, vol. 28, pp. 1541-1545 (1979).
Martin, et al, Journal of Pharmaceutical Sciences, V.76, No. 2, Issued Feb. 1987, "Synthesis and Antiviral Activity of Various Esters of
Casida, et al, Biochemical Pharmacology, V. 15, Issued 1966, "3',5'-Diesters of 5-Fluoro-2'-Deoxyuridine and Thymidine Hydrolysis by Esterases in Human, Mouse, and Insect Tissue," pp. 627-644.
Losse et al, Chemical Abstracts, vol. 118, Issued 1993, "A convenient pathway to 2'-(tert-butyloxycarbonyl)-ribonucleosides," p. 884, col. 1, abstr. No. 60026c, J. Prakt. Chem./Chem.-Ztg., 334(6), 531-532.
Bamat Michael K.
von Borstel Reid W.
Kunz Gary L.
Pro-Neuron, Inc.
LandOfFree
Compositions of chemotherapeutic agent or antiviral agent with a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of chemotherapeutic agent or antiviral agent with a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of chemotherapeutic agent or antiviral agent with a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-13677